Purple Biotech PPBT
NASDAQ PPBT
$1.11 +0.02 (+1.83%)
As of: Oct 21, 2026 · 1:14 PM EDT

Purple Biotech (PPBT) Notes Payables (2014 - 2016)

Updated

Purple Biotech (PPBT) reported Notes Payables of $129,800 for Q4 2016.

Analysis

Purple Biotech (PPBT) Notes Payables (2014 - 2016) Analysis & Trends

  • By year, Notes Payables came in at $294,000 in FY2014.
  • The Q4 2016 figure ranks as the highest quarterly Notes Payables since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn
10 Purple Biotech 530,458.98 -32.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 129,800.00
Dec 31, 2014 294,000.00
API Access

Purple Biotech Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=PPBT&period=max&api_key=YOUR_API_KEY